Prognostic factors for survival in patients with gastrointestinal stromal tumors treated with adjuvant imatinib

• Príomhchruthaitheoirí: Vilma Fleites-Calvo (Údar), Jorge Luis Soriano-García (Údar), Mayte Lima-Pérez (Údar), Jorge Luis Soriano-Lorenzo (Údar), Masiel González-Meisozo (Údar), Dunia Morales-Morgado (Údar), Carlos Domínguez Álvarez (Údar)
• Formáid: LEABHAR
• Foilsithe / Cruthaithe: Universidad de Ciencias Médicas de La Habana, 2023-06-01T00:00:00Z.
• Ábhair: article
• Rochtain ar líne: Connect to this object online.

Introduction: Gastrointestinal stromal tumors are rare neoplasms of the gastrointestinal tract. A considerable number of cases have risk factors that cause early recurrence of the disease, therefore, adjuvant therapy with imatinib in this group of patients manages to increase the disease-free interv...